caplacizumab
sanofi
['caplac']
at 10:30am cst #ash22, dr. george goshua will participate in a spotlight session debate, representing the 'against' opinion on whether most/all patients with acquired ttp should receive caplacizumab. 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.